Caplin Point Laboratories: September ’21 Results Update
Moneylife Digital Team 11 November 2021
Where other pharmaceuticals companies witnessed cost pressure due to rising raw materials prices, Caplin Point Laboratories (Caplin) reported a healthy quarter due to its differentiated model. To...
Archived Premium Content
This article is outside your subscription period. You can buy this article individually.
SINGLE ARTICLE
Rs 50-Rs 100 + GST
Access will be given ONLY to this article.
 
Get access to complete archives
Rs 5000 + GST
 
 
Already a subscriber ? Log in
Free Helpline
Legal Credit
Feedback